Barrington raised the firm’s price target on Adtalem Global Education (ATGE) to $170 from $150 and keeps an Outperform rating on the shares ahead of the fiscal Q1 report on October 30. Demand for healthcare professionals, which represents 90% of Adtalem’s enrollment, will continue to outpace supply for the foreseeable future, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATGE: